AI assistant
Barclays PLC M&A Activity 2023
5250_mrq_2023-10-06_c82d4abe-f4c3-43c8-83e0-5924f25b4702.html
M&A Activity
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 0288P
Barclays PLC
06 October 2023
| FORM 8.3 | |||||||
| IRISH TAKEOVER PANEL | |||||||
| DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, | |||||||
| TAKEOVER RULES, 2007 (AS AMENDED) | |||||||
| DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES | |||||||
| REPRESENTING 1% OR MORE | |||||||
| 1. | KEY INFORMATION | ||||||
| Name of person dealing (Note 1) | Barclays PLC. | ||||||
| Company dealt in | HORIZON THERAPEUTICS PLC | ||||||
| Class of relevant security to which the dealings being disclosed relate (Note 2) | $0.001 ordinary shares | ||||||
| Date of dealing | 05 Oct 2023 | ||||||
| 2. | INTERESTS AND SHORT POSITIONS | ||||||
| (a) | Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3) | ||||||
| Class of relevant security: | $0.001 ordinary shares | ||||||
| Long | Short | ||||||
| Number | (%) | Number | (%) | ||||
| (1) | Relevant securities | 3,727,363 | 1.63% | 60,635 | 0.03% | ||
| (2) | Derivatives (other than options): | 49,520 | 0.02% | 62,670 | 0.03% | ||
| (3) | Options and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | ||
| TOTAL: | 3,776,883 | 1.65% | 123,305 | 0.05% | |||
| (b) | Interests and short positions in relevant securities of the company, other than the class dealt in | ||||||
| Class of relevant security: | Long | Short | |||||
| Number | (%) | Number | (%) | ||||
| (1) | Relevant securities | ||||||
| (2) | Derivatives (other than options): | ||||||
| (3) | Options and agreements to purchase/sell: | ||||||
| TOTAL: | |||||||
| 3. | DEALINGS (Note 4) | ||||||
| (a) | Purchase and sales | ||||||
| Class of relevant Security | Purchase/sale | Number of securities | Price per unit | ||||
| $0.001 ordinary shares | Purchase | 100 | 116.2800 USD | ||||
| $0.001 ordinary shares | Purchase | 172 | 116.3250 USD | ||||
| $0.001 ordinary shares | Purchase | 250 | 116.3350 USD | ||||
| $0.001 ordinary shares | Purchase | 300 | 116.3200 USD | ||||
| $0.001 ordinary shares | Purchase | 547 | 116.2700 USD | ||||
| $0.001 ordinary shares | Purchase | 1,110 | 116.3195 USD | ||||
| $0.001 ordinary shares | Purchase | 1,200 | 116.2908 USD | ||||
| $0.001 ordinary shares | Purchase | 1,464 | 116.2734 USD | ||||
| $0.001 ordinary shares | Purchase | 2,136 | 116.3247 USD | ||||
| $0.001 ordinary shares | Purchase | 3,700 | 116.3033 USD | ||||
| $0.001 ordinary shares | Purchase | 4,215 | 116.2893 USD | ||||
| $0.001 ordinary shares | Purchase | 5,962 | 116.3050 USD | ||||
| $0.001 ordinary shares | Purchase | 20,818 | 116.3179 USD | ||||
| $0.001 ordinary shares | Purchase | 23,202 | 116.3104 USD | ||||
| $0.001 ordinary shares | Purchase | 23,887 | 116.3235 USD | ||||
| $0.001 ordinary shares | Purchase | 35,761 | 116.3023 USD | ||||
| $0.001 ordinary shares | Purchase | 36,470 | 116.2980 USD | ||||
| $0.001 ordinary shares | Purchase | 39,389 | 116.3225 USD | ||||
| $0.001 ordinary shares | Purchase | 58,704 | 116.3316 USD | ||||
| $0.001 ordinary shares | Purchase | 62,510 | 116.3300 USD | ||||
| $0.001 ordinary shares | Purchase | 67,937 | 116.3194 USD | ||||
| $0.001 ordinary shares | Purchase | 76,932 | 116.3500 USD | ||||
| $0.001 ordinary shares | Purchase | 112,475 | 116.3221 USD | ||||
| $0.001 ordinary shares | Purchase | 1,532,570 | 116.3017 USD | ||||
| $0.001 ordinary shares | Purchase | 17,911,156 | 116.3000 USD | ||||
| $0.001 ordinary shares | Sale | 5 | 116.3600 USD | ||||
| $0.001 ordinary shares | Sale | 100 | 116.3305 USD | ||||
| $0.001 ordinary shares | Sale | 100 | 116.2800 USD | ||||
| $0.001 ordinary shares | Sale | 100 | 116.3200 USD | ||||
| $0.001 ordinary shares | Sale | 161 | 116.3413 USD | ||||
| $0.001 ordinary shares | Sale | 400 | 116.3300 USD | ||||
| $0.001 ordinary shares | Sale | 408 | 116.3324 USD | ||||
| $0.001 ordinary shares | Sale | 443 | 116.3311 USD | ||||
| $0.001 ordinary shares | Sale | 669 | 116.3432 USD | ||||
| $0.001 ordinary shares | Sale | 1,300 | 116.3576 USD | ||||
| $0.001 ordinary shares | Sale | 1,300 | 116.3007 USD | ||||
| $0.001 ordinary shares | Sale | 1,324 | 116.3277 USD | ||||
| $0.001 ordinary shares | Sale | 1,990 | 116.3262 USD | ||||
| $0.001 ordinary shares | Sale | 6,071 | 116.3092 USD | ||||
| $0.001 ordinary shares | Sale | 6,947 | 116.2907 USD | ||||
| $0.001 ordinary shares | Sale | 15,336 | 116.3190 USD | ||||
| $0.001 ordinary shares | Sale | 20,258 | 116.3267 USD | ||||
| $0.001 ordinary shares | Sale | 20,667 | 116.3118 USD | ||||
| $0.001 ordinary shares | Sale | 21,744 | 116.3036 USD | ||||
| $0.001 ordinary shares | Sale | 42,246 | 116.3314 USD | ||||
| $0.001 ordinary shares | Sale | 57,379 | 116.3317 USD | ||||
| $0.001 ordinary shares | Sale | 75,632 | 116.3500 USD | ||||
| $0.001 ordinary shares | Sale | 1,838,582 | 116.3043 USD | ||||
| $0.001 ordinary shares | Sale | 17,537,546 | 116.3000 USD | ||||
| (b) | Derivatives transactions (other than option transactions) | ||||||
| Product Name | Nature of transaction | Number of relevant securities | Price per unit | ||||
| (c) | Options transactions in respect of existing securities | ||||||
| (i) | Writing, selling, purchasing or varying | ||||||
| Class of relevant security |
Product description |
Writing, purchasing, selling, varying etc |
Number of securities to which option relates |
Exercise price per unit |
Type | Expiry date |
Option money paid/ received per unit |
| (ii) | Exercising | ||||||
| Product name | Number of securities |
Exercise price per unit |
|||||
| (d) | Other dealings (including transactions in respect of new securities) (Note 4) | ||||||
| Nature of transaction | Details | Price per unit (if applicable) |
|||||
| 4. | OTHER INFORMATION | ||||||
| Agreements, arrangements or understandings relating to options or derivatives | |||||||
| Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. |
|||||||
| NONE | |||||||
| Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
| Date of disclosure: | 06 Oct 2023 | ||||||
| Contact name: | Large Holdings Regulatory Operations | ||||||
| Telephone number: | 020 3134 7213 | ||||||
| If a connected EFM, name of offeree/offeror with which connected | |||||||
| If a connected EFM, state nature of connection |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
ITPMZMGGDVGGFZM